Valuation: BioElectronics Corporation

Market Cap 12.35M 10.81M 9.96M 9.22M 17.5M 1.18B 17.79M 119M 46.78M 579M 46.37M 45.37M 2.01B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.48M 20.73M 19.18M 36.4M 2.45B 37.01M 248M 97.31M 1.2B 96.46M 94.37M 4.17B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month-25.00%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 14/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 14/06/2020
Director/Board Member - 14/11/2019
Director/Board Member - 02/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-40.00% 7.41M
+2.86%+0.24%+24.97%+2.14% 195B
-0.86%-3.39%-22.07%+24.23% 146B
+0.40%-0.33%-56.30%-13.96% 66.87B
-2.47%-3.22%+18.32%+1.19% 52.59B
+0.31%-1.40%-27.94%-30.64% 43.85B
+3.50%+2.22%+10.13%+14.18% 37.73B
+2.44%-0.57%+8.00%+42.77% 37.03B
+1.27%-0.56%-18.57%-3.41% 30.07B
+0.03%-1.32%-14.32%-18.74% 29.43B
Average +0.37%-1.70%-2.78%-2.22% 63.83B
Weighted average by Cap. -0.26%-1.81%-4.19%+5.01%

Financials

2020 2021
Net sales 830K 726K 669K 619K 1.18M 79.18M 1.19M 8.01M 3.14M 38.88M 3.11M 3.05M 135M 1.61M 1.41M 1.3M 1.2M 2.28M 154M 2.32M 15.55M 6.1M 75.44M 6.04M 5.91M 261M
Net income -1.16M -1.01M -936K -866K -1.64M -111M -1.67M -11.2M -4.39M -54.36M -4.35M -4.26M -188M -290K -254K -234K -216K -411K -27.66M -417K -2.8M -1.1M -13.58M -1.09M -1.06M -47.06M
Net Debt 13.07M 11.43M 10.54M 9.75M 18.51M 1.25B 18.82M 126M 49.49M 613M 49.06M 48M 2.12B 13.34M 11.67M 10.76M 9.96M 18.9M 1.27B 19.22M 129M 50.53M 625M 50.09M 49M 2.17B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
09/07/26 US$0.000300 0.00% 1,760,525
08/07/26 US$0.000300 0.00% 4,523,182
07/07/26 US$0.000300 +20.00% 10,253,333
06/07/26 US$0.000250 -16.67% 4,187,384
02/07/26 US$0.000300 0.00% 2,540,317
  1. Stock Market
  2. Stocks
  3. BIEL Stock